Targeted Delivery of Antineoplastic Agent to Bone: Biodistribution Studies of Technetium-99m-Labeled Gem-Bisphosphonate Conjugate of Methotrexate

Fazle Hosain; Richard P. Spencer; Helene M. Couthon; Georges L. Sturtz

Research ArticleLaboratory Studies

Targeted Delivery of Antineoplastic Agent to Bone: Biodistribution Studies of Technetium-99m-Labeled Gem-Bisphosphonate Conjugate of Methotrexate

Fazle Hosain, Richard P. Spencer, Helene M. Couthon and Georges L. Sturtz

Journal of Nuclear Medicine January 1996, 37 (1) 105-107;

Fazle Hosain

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Richard P. Spencer

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Helene M. Couthon

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Georges L. Sturtz

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Info & Metrics
PDF

This is a PDF-only article. The first page of the PDF of this article appears above.

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 37, Issue 1

January 1, 1996

Table of Contents
Table of Contents (PDF)
Index by author
Advertising (PDF)
Back Matter (PDF)
Ed Board (PDF)
Front Matter (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Targeted Delivery of Antineoplastic Agent to Bone: Biodistribution Studies of Technetium-99m-Labeled Gem-Bisphosphonate Conjugate of Methotrexate

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Targeted Delivery of Antineoplastic Agent to Bone: Biodistribution Studies of Technetium-99m-Labeled Gem-Bisphosphonate Conjugate of Methotrexate

Fazle Hosain, Richard P. Spencer, Helene M. Couthon, Georges L. Sturtz

Journal of Nuclear Medicine Jan 1996, 37 (1) 105-107;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Targeted Delivery of Antineoplastic Agent to Bone: Biodistribution Studies of Technetium-99m-Labeled Gem-Bisphosphonate Conjugate of Methotrexate

Fazle Hosain, Richard P. Spencer, Helene M. Couthon, Georges L. Sturtz

Journal of Nuclear Medicine Jan 1996, 37 (1) 105-107;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Info & Metrics
PDF

No related articles found.

PubMed
Google Scholar

Cited By...

No citing articles found.

Google Scholar

Main menu

User menu

Search

Targeted Delivery of Antineoplastic Agent to Bone: Biodistribution Studies of Technetium-99m-Labeled Gem-Bisphosphonate Conjugate of Methotrexate

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles